CF Foundation-accredited care centers play an important role in research. They collect information on the health status of their patients with CF who agree to participate, and report that data to the CF Foundation Patient Registry. The information is available in aggregate to the CF community each year through the Data Report, the Highlights Report, and the Care Center Finder.
Site Search
Showing 1 - 10 of 60 results
News
|
May 6, 2011
|
1 min read
News
|
Nov. 8, 2011
|
2 min read
The New England Journal of Medicine, the world's most influential and widely read medical periodical, features a study this week about a Phase 2 clinical trial of VX-770, an oral drug in development that targets the root cause of cystic fibrosis.
News
|
Nov. 17, 2010
|
3 min read
News
|
Sept. 16, 2008
|
1 min read
News
|
April 11, 2008
|
1 min read
News
|
Aug. 20, 2008
|
1 min read
News
|
Aug. 11, 2014
|
2 min read
News
|
July 29, 2010
|
2 min read
The U.S. Food and Drug Administration approved the use of lumacaftor/ivacaftor (Orkambi®) today for children with cystic fibrosis ages 2 to 5 who have two copies of the F508del mutation.
News
|
Aug. 7, 2018
|
3 min read